(Applicant?s Description) The H. Lee Moffitt Cancer Center requests renewal of its National Cancer Institute (NCI) Center Core Support Grant (CCSG) for years 4-8 and designation as a Comprehensive Cancer Center. The Center has continued its remarkable growth, nearly doubling both its NCI and total peer reviewed funding during the first two years of the CCSG. The Center has added nearly 50,000 sq ft of new research space and will add another 200,000 sq ft of new research space in 2003. All of the commitments to the growth of the Center and its scientific staff will allow it to achieve its sole mission of """"""""contributing to the prevention and cure of cancer."""""""" As one of only a handful of freestanding centers located on a university campus, the Moffitt Cancer Center enjoys the benefits of being freestanding within the intellectual arena of a university based matrix center. In addition, the Center benefits from extraordinary support from the State of Florida, the University of South Florida and its own Board of Directors. The Center, which brings together all clinical and research approaches to cancer at the University of South Florida under one management structure, seeks support for four scientific programs, 11 shared resources, seven staff investigators, developmental funds and administration. In 1997, the Cancer Center asked the site reviewers to recognize the Center?s potential to become a major NCI designated cancer center and contributor to the national cancer research program. The Moffitt Cancer Center has remained true to that commitment and seeks to expand upon it.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
7P30CA076292-08
Application #
6858632
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1998-02-19
Project End
2007-01-31
Budget Start
2005-03-16
Budget End
2007-01-31
Support Year
8
Fiscal Year
2005
Total Cost
$2,241,839
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Hoffman, Melissa A; Fang, Bin; Haura, Eric B et al. (2018) Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer. J Proteome Res 17:63-75
Kahen, Elliot John; Brohl, Andrew; Yu, Diana et al. (2018) Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors. Oncotarget 9:22571-22585
Gonzalez, Brian D; Small, Brent J; Cases, Mallory G et al. (2018) Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia. Cancer 124:499-506
Puri, Sonam; Hyland, Kelly A; Weiss, Kristine Crowe et al. (2018) Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors. Support Care Cancer 26:2911-2918
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Eroglu, Zeynep; Zaretsky, Jesse M; Hu-Lieskovan, Siwen et al. (2018) High response rate to PD-1 blockade in desmoplastic melanomas. Nature 553:347-350
Kasting, Monica L; Christy, Shannon M; Sutton, Steven K et al. (2018) Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Prev Med 116:143-149
Phadke, Manali; Remsing Rix, Lily L; Smalley, Inna et al. (2018) Dabrafenib inhibits the growth of BRAF-WT cancers through CDK16 and NEK9 inhibition. Mol Oncol 12:74-88
Park, Jae H; Rivière, Isabelle; Gonen, Mithat et al. (2018) Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. N Engl J Med 378:449-459
Jiang, Kun; Neill, Kevin; Cowden, Daniel et al. (2018) Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus. Appl Immunohistochem Mol Morphol 26:552-556

Showing the most recent 10 out of 1254 publications